BGCKX | JMNAX | BGCKX / JMNAX | |
Total Expense Ratio | 1.29 | 2.74 | 47% |
Annual Report Gross Expense Ratio | 1.31 | 2.87 | 46% |
Fund Existence | 10 years | 24 years | - |
Gain YTD | 11.259 | 3.591 | 314% |
Front Load | N/A | 5% | - |
Min. Initial Investment | 5000000 | 1000 | 500,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 6.88B | 407M | 1,691% |
Annual Yield % from dividends | 9.94 | 2.34 | 426% |
Returns for 1 year | 13.65 | 3.02 | 452% |
Returns for 3 years | 60.24 | 30.34 | 199% |
Returns for 5 years | 60.80 | 20.58 | 295% |
Returns for 10 years | N/A | 10.30 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PXLIX | 14.34 | 0.06 | +0.42% |
Impax Large Cap Fund Institutional | |||
FIRAX | 10.33 | 0.01 | +0.10% |
Fidelity Advisor Intl Real Estate A | |||
GIRMX | 29.64 | -0.05 | -0.17% |
Goldman Sachs Emerging Markets Eq Inv | |||
BIPIX | 56.46 | -0.10 | -0.18% |
ProFunds Biotechnology UltraSector Inv | |||
MINJX | 45.87 | -0.31 | -0.67% |
MFS International Intrinsic Value R6 |